| Dr Nicole Ann Long, DO | |
|
277 White St Ne, Abingdon, VA 24210-2913 | |
| (276) 628-4335 | |
| (276) 628-3195 |
| Full Name | Dr Nicole Ann Long |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 277 White St Ne, Abingdon, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962609289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5101017337 (Michigan) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 0102202854 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johnston Memorial Hospital | Abingdon, VA | Hospital |
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Holston Medical Group Pc | 8224935754 | 221 |
| Holston Medical Group Pc | 8224935754 | 221 |
News Archive
Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
A new method to increase the efficiency of contrast radiology may open the way to earlier and more reliable diagnosis of, for example, breast cancer. With new integrated electronics and signal processing, the image quality can be improved sharply.
OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."
› Verified 5 days ago
| Entity Name | Holston Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831110667 PECOS PAC ID: 8224935754 Enrollment ID: O20031216000416 |
News Archive
Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
A new method to increase the efficiency of contrast radiology may open the way to earlier and more reliable diagnosis of, for example, breast cancer. With new integrated electronics and signal processing, the image quality can be improved sharply.
OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."
› Verified 5 days ago
| Entity Name | State Of Franklin Healthcare Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063459410 PECOS PAC ID: 2466346291 Enrollment ID: O20040211001101 |
News Archive
Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
A new method to increase the efficiency of contrast radiology may open the way to earlier and more reliable diagnosis of, for example, breast cancer. With new integrated electronics and signal processing, the image quality can be improved sharply.
OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."
› Verified 5 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
A new method to increase the efficiency of contrast radiology may open the way to earlier and more reliable diagnosis of, for example, breast cancer. With new integrated electronics and signal processing, the image quality can be improved sharply.
OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole Ann Long, DO 277 White St Ne, Abingdon, VA 24210-2913 Ph: (276) 628-4335 | Dr Nicole Ann Long, DO 277 White St Ne, Abingdon, VA 24210-2913 Ph: (276) 628-4335 |
News Archive
Increased physical activity appears to be associated with a lower risk of cancer-specific and overall death in men with a history of colorectal cancer that has not spread to other parts of the body, according to a report in the December 14/28 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that in the follow-up portion of its Phase 2 clinical trial in patients with diabetic foot ulcers, the percentage of patients treated with the therapeutic dose of DSC127 with complete healing at 24 weeks following trial enrollment was 73% in the intent-to-treat population and 85% in the per-protocol population, a difference of 27 and 33 percentage points, respectively, compared with patients treated with placebo/standard of care.
A new method to increase the efficiency of contrast radiology may open the way to earlier and more reliable diagnosis of, for example, breast cancer. With new integrated electronics and signal processing, the image quality can be improved sharply.
OXIS INTERNATIONAL, INC. and THE ESTEE LAUDER COMPANIES INC. announce today that they have resolved a dispute between an Estee Lauder subsidiary, Applied Genetics Incorporated Dermatics, and Oxis over technology related to U.S. Patent No. 6,103,746 and U.S. Patent No. 6,479,533, entitled "Methods and Compositions for the Protection of Mitochondria."
› Verified 5 days ago
Dr. Melanie Ann Leight, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 277 White St Ne, Abingdon, VA 24210 Phone: 276-628-4335 Fax: 276-628-3195 | |
Dr. Jay Wayne Lavigne, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 277 White St Ne, Abingdon, VA 24210 Phone: 276-628-4335 Fax: 276-628-3195 | |
Roger Leroy Cass, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 200, Abingdon, VA 24211 Phone: 276-628-4335 | |
Brett Allen Manthey, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 407 E Main St, Abingdon, VA 24210 Phone: 276-628-4232 Fax: 276-676-4552 | |
Dr. James D Moore Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 227 W Main St, Abingdon, VA 24210 Phone: 276-628-6011 Fax: 276-628-3923 | |
Wendy Replogle Strawbridge, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr, Suite 300, Abingdon, VA 24211 Phone: 276-258-2732 Fax: 276-258-2735 | |
Dr. Kenneth John Baker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 16000 Johnston Memorial Dr Ste 200, Abingdon, VA 24211 Phone: 276-628-4335 |